unknown
Stage
About
Arcus Bio is a clinical-stage biopharmaceutical company developing small molecule and antibody therapies that target cancer through combination treatments focused on immuno-oncology pathways.
Explore Arcus Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.